Conservative management of patients with early endometrial carcinoma: A systematic review

Clinical and Translational Oncology

Volumn 10, Issue 3, 2008, Pages 155-162

  Chiva de Agustín, Luis ^a   Sastre, Fernando Lapuente ^a   Galán, Virginia Corraliza ^a   Galainena, Luis Granados ^a   Martín, Antonio González ^a   Cortijo, Lucía González ^a   González, Natalia Carballo ^a  

^a MD ANDERSON CANCER CENTER   (Spain)

Author keywords

Endometrial adenocarcinoma; Fertility; Hormonal therapy

Indexed keywords

ANTIESTROGEN; AROMATASE INHIBITOR; GESTAGEN; GONADORELIN AGONIST; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CURETTAGE; DRUG RESPONSE; ENDOMETRIUM CARCINOMA; FEMALE FERTILITY; HUMAN; HYSTERECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; REPRODUCTIVE SUCCESS; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; ADENOCARCINOMA; ENDOMETRIUM TUMOR; FEMALE; FERTILITY; PATHOLOGY; PREGNANCY; PREGNANCY OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, HORMONAL; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY; HUMANS; PREGNANCY; PREGNANCY OUTCOME;

EID: 45549087106     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-008-0173-1     Document Type: Review

References (78)

1. (2004) Cancer facts & figures, 2004. American Cancer Society, Atlanta, GA
2. Ibáñez E, Chiva L, Rodríguez-Escudero FJ (1999) Resultados de la Encuesta Nacional sobre Carcinoma de Endometrio Diagnosticado en 1993. En Avances en Ginecología Oncológica. Rodríguez-Escudero Eds, Caceres
3. Herruzo A, Carmona M, Chiva L et al (2003) Evolución de los resultados del tratamiento del cáncer de endometrio en España entre 1980 y 1990. Análisis de las casuísticas nacionales de la sociedad española la de ginecología y obstetricia. Prog Obstet Ginecol 45:54-62
4. Creasman WT (2002) Adenocarcinoma of the uterus. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology. St. Louis, MO, Mosby Inc, pp 289-350
5. Crissman JD, Azoury RS, Barnes AE, Schellhas HF (1981) Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 57:699-704
6. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP (1998) Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91:349-354
7. Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS (1985) Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 20:139-155
8. Gallup DG, Stock RJ (1984) Adenocarcinoma of the endometrium in women 40 years of age and younger. Obstet Gynecol 64:417
9. Patsner B (2000) Endometrial cancer in women 45 years of age or younger. Eur J Gynaecol Oncol 21:249-250
10. Tran BN, Connell PP, Waggoner S et al (2000) Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 23:476-480
11. Fahri DC, Nosanchuk J, Silverberg SG (1986) Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 68:741-745
12. Gitsch G, Hanzal E, Jensen D, Hacker NF (1995) Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 85:504-508
13. Lee NK, Cheung MK, Shin JY et al (2007) Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 109:655-662
14. Walsh C, Holschneider C, Hoang Y et al (2005) Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 106:693-699
15. Kendall BS, Ronnett BM, Isacson C et al (1998) Reproducibility of the diagnosis of endometrial hyperplasia, AH, and well-differentiated carcinoma. Am J Surg Pathol 22:1012-1019
16. Ehrlich CE, Young PC, Stehman FB et al (1988) Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158:796-807
17. Pace S, Grassi A, Ferrero S et al (1995) Diagnostic methods of early detection of endometrial hyperplasia and cancer. Eur J Gynaecol Oncol 16:373-381
18. Bergeron C, Nogales FF, Masseroli M et al (1999) A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 23:1102-1108
19. Mutter GL and the Endometrial Collaborative Group (2000) Endometrial Intraepithelial Neoplasia (EIN): Will it bring order to chaos? Gynecol Oncol 76:287-290
20. Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56:403-412
21. Baak JPA, Wisse-Brekelmans ECM, Fleege JC et al (1992) Assessment of the risk of endometrial cancer in hyperplasia by means of morphological and morphometrical features. Path Res Pract 188:856-859
22. Larson DM, Johnson KK, Broste SK et al (1995) Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 86:38-42
23. Kinkel K, Kaji Y, Yu KK et al (1999) Radiologic staging in patients with endometrial cancer: A metaanalysis. Radiology 212:711-718
24. Frei KA, Kinkel K (2001) Staging endometrial cancer: Role of magnetic resonance imaging. J Magn Reson Imaging 13:850-855
25. Taieb S, Ceugnart L, Leblanc E et al (2002) MR imaging of endometrial carcinoma: Role and limits. Bull Cancer 89:963-968
26. Yoshida Y, Kurokawa T, Yagihara R, Kotsuji F (2006) The usefulness of FES-PET for the prediction of the therapeutic effect of hormonal therapy in a patient with endometrial cancer - A case report (abstract). J Obstet Gynaecol Res 58:406
27. Yahata T, Fujita K, Aoki Y, Tanaka K (2006) Long-term conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod 21:1070-1075
28. Ushijima K, Yahata H, Yoshikawa H et al (2007) Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25:2798-2803
29. Varga A, Henriksen E (1961) Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometrial carcinoma. Obstet Gynecol 18:658-672
30. Montz FJ, Bristow RE, Bovicelli A et al (2002) Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 186:651-657
31. Sǎparac V, Ujevi B, Ujevi M et al (2006) Successful pregnancy after hysteroscopic removal of grade I endometrial carcinoma in a young woman with Lynch syndrome. Int J Gynecol Cancer 16[Suppl 1]:442-445
32. Vilos GD, Ettler HC, Edris F et al (2007) Endometrioid adenocarcinoma treated by hysteroscopic endomyometrial resection. J Min Inv Gyn 14:119-122
33. Emons G, Heyl W (2000) Hormonal treatment of endometrial cancer. J Cancer Res Clin Oncol 126:619-623
34. Gallagher CJ, Oliver RT, Ohram DH (1991) A new treatment for endometrial cancer with gonadotropin-releasing hormone analogue. Br J Obstet Gynaecol 98:1037-1041
35. De Vriese G, Bonte J (1993) Possible role of goserelin, an LH-RH agonist in the treatment of gynaecological cancers. Eur J Gynaecol Oncol 14:187-191
36. Agorastos T, Bontis J, Vakiani A et al (1997) Treatment of endometrial hyperplasias with gonadotrophin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data. Gynecol Oncol 65:102-114
37. Kullander S (1992) Treatment of endometrial cancer with GnRH analogues. Recent Result Cancer Res 124:69-73
38. Saegusa M, Okayasu I (1998) Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer 83:111-121
39. Emons G, Schröder B, Ortmann O et al (1993) High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 77:1458-1464
40. Deligdisch L (1993) Effects of hormone therapy on the endometrium. Mod Pathol 6:94-106
41. Podratz KC, O'Brien PC, Malkasian GD Jr et al (1985) Effects of progestational agents in treatment of endometrial carcinoma. Obstet Gynecol 66:106-110
42. Ramirez PT, Frumovitz M, Bodurka DC et al (2004) Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: A literature review. Gynecol Oncol 95:133-138
43. Yazbeck C, Dhainaut C, Thoury A et al (2005) Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG 112:317-320
44. Nakao Y, Nomiyama M, Kojima K et al (2004) Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma. Gynecol Obstet Invest 58:68-71
45. Yarali H, Bozdag G, Aksu T, Ayhan A (2004) A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertil Steril 81:214-216
46. Paulson RJ, Sauer MV, Lobo RA (1990) Pregnancy after in vitro fertilization in a patient with stage I endometrial carcinoma treated with progestins. Fertil Steril 54:735-736
47. Niwa K, Yokoyama Y, Tanaka T et al (1994) Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Arch Gynecol Obstet 255:91-94
48. Kimmig R, Strowitzki T, Muller-Hocker J et al (1995) Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 58:255-257
49. Kim YB, Holschneider CH, Ghosh K et al (1997) Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 79:320-327
50. Randall TC, Kurman RJ (1997) Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90:434-440
51. Niwa K, Morishita S, Hashimoto M et al (1997) Conservative therapy for endometrial carcinoma in young women treated with repeated curettage and progestogen. Int J Clin Oncol 2:165-169
52. Zanetta G, Gabriele A, Losa G et al (1997) Conservative management of endometrial carcinoma with prolonged preservation of the uterus in a young patient. Int J Gynecol Cancer 7:332-334
53. Vinker S, Shani A, Open M et al (1999) Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate? Eur J Obstet Gynecol Reprod Biol 83:63-65
54. Sardi J, Anchezar Henry JP, Paniceres G et al (1998) Primary hormonal treatment for early endometrial carcinoma. Eur J Gynaecol Oncol 19: 565-568
55. Schammel DP, Mittal KR, Kaplan K et al (1998) Endometrial adenocarcinoma associated with intrauterine pregnancy. A report of five cases and a review of the literature. Int J Gynecol Pathol 17:327-335
56. Kowalczyk CL, Malone J Jr, Peterson EP et al (1999) Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report. J Reprod Med 44:57-60
57. Jobo T, Imai M, Kawaguchi M et al (2000) Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases. Eur J Gynecol Oncol 21:119-122
58. Mitsushita J, Toki T, Kato K et al (2000) Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxy progesterone acetate. Gynecol Oncol 79:129-132
59. Imai M, Jobo T, Sato R et al (2001) Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus - Usefulness and limitations. Eur J Gynaecol Oncol 22:217-220
60. Kaku T, Yoshikawa H, Tsuda H et al (2001) Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: Central pathologic review and treatment outcome. Cancer Lett 167:39-48
61. Wang CB, Wang CJ, Huang HJ et al (2002) Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 94:2192-2198
62. Shibahara H, Shigeta M, Toji H et al (1999) Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection. Hum Reprod 14:1908-1911
63. O'Neill RT (1970) Pregnancy following hormonal therapy for adenocarcinoma of the endometrium. Am J Obstet Gynecol 108:318-321
64. Muechler EK, Bonfiglio T, Choate J, Huang KE (1986) Pregnancy induced with menotropins in a woman with polycystic ovaries, endometrial hyperplasia, and adenocarcinoma. Fertil Steril 46:973-975
65. Paulson RJ, Sauer MV, Lobo RA (1990) Pregnancy after in vitro fertilization in a patient with stage I endometrial carcinoma treated with progestins. Fertil Steril 54:735-736
66. Lai CH, Hsueh S, Chao AS, Soong YK (1994) Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma. Br J Obstet Gynaecol 101:547-549
67. Niwa K, Yokoyama Y, Tanaka T et al (1994) Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Arch Gynecol Obstet 255:91-94
68. Kimmig R, Strowitzki T, Müller-Höcker J et al (1995) Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 58:255-257
69. Kowalczyk CL, Malone J, Peterson EP et al (1999) Well differentiated endometrial adenocarcinoma in an infertility patient with later conception. J Reprod Med 44:57-60
70. Mitsushita J, Toshihiko T, Kato K et al (2000) Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecol Oncol 79:129-132
71. Pinto AB, Gopal MG, Herzog TJ et al (2001) Successful in vitro fertilization pregnancy after conservative management of endometrial cancer. Fertil Steril 76:826-829
72. Lowe MP, Bender D, Sood AK et al (2002) Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction. Fertil Steril 77:188-189
73. Zuckerman B, Lavie O, Neuman M et al (1998) Endometrial stage I-grade II. Conservative treatment followed by a healthy twin pregnancy. Int J Gynecol Cancer 8:172-174
74. Huang SY, Jung SM, Ng KK et al (2005) Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment. Gynecol Oncol 97:652-655
75. Yasuda M, Matsui N, Kajiwara H et al (2004) Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation. Pathol Int 54:451-456
76. Ferrandina G, Zannoni GF, Gallotta V et al (2005) Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol Oncol 99:215-217
77. Ota T, Yoshida M, Kimura M, Kinoshita K (2005) Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer 15:657-662
78. Cormio G, Martino R, Loizzi V et al (2006) A rare case of choroidal metastasis presented after conservative management of endometrial cancer. Int J Gynecol Cancer 16:2044-2048